Suchergebnisse - (Subject:"ritonavir")

PubPharm (28)

1

Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong : an observational study

enthalten in: Lancet (London, England) | 2022

von Wong, C. | Au, I. | Lau, K. | +3

CommentIn: Lancet. 2022 Oct 8;400(10359):1175-1176. - PMID 36215994

2

The global COVID-19 treatment divide

enthalten in: Lancet (London, England) | 2022

von Usher, A.

3

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: Lancet (London, England) | 2020

von RECOVERY Collaborative Group | Horby, P. | Mafham, M. | +24

CommentIn: Lancet. 2020 Oct 24;396(10259):1310-1311. - PMID 33031761

4

Interferon beta-1b for COVID-19

enthalten in: Lancet (London, England) | 2020

von Shalhoub, S.

CommentOn: Lancet. 2020 May 30;395(10238):1695-1704. - PMID 32401715

5

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label, randomised, phase 2 trial

enthalten in: Lancet (London, England) | 2020

von Hung, I. | Lung, K. | Tso, E. | +41

CommentIn: Lancet. 2020 May 30;395(10238):1670-1671. - PMID 32401712

6

Flooded by the torrent : the COVID-19 drug pipeline

enthalten in: Lancet (London, England) | 2020

von Mullard, A.

CommentOn: N Engl J Med. 2020 Mar 18;:null. - PMID 32187464

7

Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174) : a randomised controlled trial

enthalten in: Lancet (London, England) | 2016

von Nagot, N. | Kankasa, C. | Tumwine, J. | +98

CommentIn: Lancet. 2016 Feb 6;387(10018):513-4. - PMID 26603916

8

Towards interferon-free treatment for all HCV genotypes

enthalten in: Lancet (London, England) | 2015

von Wedemeyer, H.

CommentOn: Lancet. 2015 Jun 20;385(9986):2502-9. - PMID 25837829

9

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I) : a randomised, open-label trial

enthalten in: Lancet (London, England) | 2015

von Hézode, C. | Asselah, T. | Reddy, K. | +11

CommentIn: Lancet. 2015 Jun 20;385(9986):2443-5. - PMID 25837828

10

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1 : 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

enthalten in: Lancet (London, England) | 2014

von Raffi, F. | Babiker, A. | Richert, L. | +117

CommentIn: Lancet. 2014 Nov 29;384(9958):1908-10. - PMID 25103175